Research on chronic inflammatory lung diseases
Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases: The RINNOPARI Project
NA · CHU de Reims · NCT02924818
This study looks at people with chronic lung diseases to see how different factors relate to their conditions and help find better treatments.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 225 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CHU de Reims (other) |
| Locations | 1 site (Reims) |
| Trial ID | NCT02924818 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients diagnosed with chronic inflammatory pulmonary diseases such as COPD, interstitial lung diseases, bronchiectasis, and cystic fibrosis. It aims to analyze various characteristics including clinical, demographic, biological, morphological, pathological, and microbiological features to better understand these conditions. By assessing the associations between these features, the study seeks to enhance the understanding of the diseases' pathophysiology and inform innovative treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with COPD, cystic fibrosis, bronchiectasis, or interstitial lung diseases.
Not a fit: Patients under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients with chronic inflammatory lung diseases.
How similar studies have performed: Other studies have shown success in understanding chronic inflammatory diseases through similar comprehensive approaches, indicating potential for meaningful advancements.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (\>18 year-old) with COPD, CF, bronchiectasis or ILD Exclusion Criteria: * \<18 year-old
Where this trial is running
Reims
- Chu Reims — Reims, France (RECRUITING)
Study contacts
- Study coordinator: Gaëtan Deslée
- Email: gdeslee@chu-reims.fr
- Phone: 326787611
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Inflammatory Pulmonary Diseases